Octreotide depot (GP Pharm)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameOctreotide depot (GP Pharm)
Drug Alias NameOctreotide LARMinoctreOctreotide MAR
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGrowth hormone releasing factor antagonistsSomatostatin receptor agonists
TargetsSomatostatin receptorGrowth hormone releasing factor
Therapy Area/IndicationsDiarrheaAcromegalyMalignant Carcinoid Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGp Pharm Sa
China Registration ClassN/A

Develop Information

Active CompaniesGp Pharm Sa
Inactive CompaniesN/A
Active IndicationsDiarrheaAcromegalyMalignant Carcinoid Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A